Type 2 Diabetes

Disease State Hub

Podcasts

podcast

Diabetes Medication Use and Common Eye Disorders

01/14/2024

In this podcast, Joëlle E. Vergroesen, MSc, discusses the results of her team's study examining how the use of metformin, insulin, and sulfonylurea derivatives may impact the risk of open-angle glaucoma,...

01/14/2024

Nutrition

Nutrition

Achieving Remission of Type 2 Diabetes Through Lifestyle Medicine

11/28/2023

In this podcast, Caroline Trapp, DNP, ANP-BC, CDCES, talks about ways to achieve partial and full remission of type 2 diabetes and how certified diabetes care and education specialists can identify the type...

11/28/2023

Podcast

Podcast

Scalable Technology-Enabled, Evidence-Based Diabetes Care Pathway for Older Adults

10/20/2023

Livleen Gill, MBA, RDN, LDN, FAND

In this podcast, Livleen Gill, MBA, RDN, LDN, FAND, discusses creating a standardized care delivery system for older adults with type 2 diabetes in Maryland, connecting health care with community-based...

10/20/2023

Liver Disease

Kim Carmichael, MD, on NAFLD in Diabetes: What Primary Care Should Know

12/20/2017

Kim Carmichael, MD, author of Consultant's monthly Diabetes Q+A column, talks about his latest column on NAFLD in diabetes patients.

12/20/2017

Research Summaries

Research summary

Gastric Bypass Surgery Improves Continued Type 2 Diabetes Remission, Even After Weight Recurrence

03/22/2024

Jessica Ganga

Researchers sought to determine whether patients with type 2 diabetes and obesity experience continued type 2 diabetes remission.

03/22/2024

FDA Alert

FDA Approves Semaglutide For Reducing Serious Cardiovascular Events Among Adults With Heart Disease and Obesity, Overweight

03/21/2024

Anthony Calabro, MA

On March 8, the FDA approved the injectable weight loss medication, semaglutide, for reducing the risk of cardiovascular events such as heart attack, stroke, and cardiovascular death in adults with heart...

03/21/2024

Roundtable Wrap-Up

Continuous Glucose Monitoring: What Should Clinicians Do With All That Data?

01/12/2024

Carol Wysham, MD, Hope Warshaw, MMSc, RD, CDCES, BC-ADM, Eugene E. Wright, Jr., MD

Carol Wysham, MD, Hope Warshaw, MMSc, RD, CDCES, BC-ADM, Eugene E. Wright, Jr., MD ...

In this Roundtable Wrap-Up, we offer an abbreviated version of the roundtable discussion on the multidisciplinary approach to managing people with diabetes, the importance of diabetes self-care and...

01/12/2024

Research Summary

Semaglutide May Not Worsen Diabetic Retinopathy in Patients Using The Medication

01/04/2024

Jessica Ganga

Researchers evaluated the popular diabetes medication, semaglutide, to determine whether it causes or worsens diabetic retinopathy in patients using the medication. Their findings were presented at AAO 2023...

01/04/2024

Research Summary

Semaglutide Provides Benefits for Patients With HFpEF and Obesity

11/22/2023

Anthony Calabro, MA

Researchers compared the effects of once-weekly semaglutide (2.4 mg) with a placebo during a 52-week period in patients with HFpEF and a BMI of 30 or higher.

11/22/2023

April 2024

Current Issue

April 2024

Volume 64

Issue 4